Author
Soldati S, Bär A, Vladymyrov M, Glavin D, McGrath JL, Gosselet F, Nishihara H, Susan Goelz S, Engelhardt B*
Publish：J Neuroinflammation.
Link：https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-023-02797-8
High levels of endothelial ICAM-1 prohibit natalizumab mediated abrogation of CD4(+) T cell arrest on the inflamed BBB under flow in vitro.